![William Collier](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
William Collier
Direttore/Membro del Consiglio presso Genevant Sciences Corp.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di William Collier
Società | Posizione | Inizio | Fine |
---|---|---|---|
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di William Collier
Precedenti posizioni note di William Collier
Società | Posizione | Inizio | Fine |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Direttore/Membro del Consiglio | 24/06/2019 | 31/12/2023 |
Amministratore Delegato | 24/06/2019 | 31/12/2023 | |
Contatto Relazioni con gli Investitori | 24/06/2019 | 21/09/2021 | |
Public Communications Contact | 24/06/2019 | - | |
Presidente | 24/06/2019 | 31/12/2023 | |
Arbutus Biopharma, Inc.
![]() Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Amministratore Delegato | - | 31/12/2023 |
Presidente | - | 31/12/2023 | |
International Partnership for Microbicides
![]() International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Direttore/Membro del Consiglio | 01/01/2018 | 01/01/2021 |
Aids United | Direttore/Membro del Consiglio | 01/01/2011 | 01/01/2018 |
Glaxowellcom | Corporate Officer/Principal | - | - |
ViiV Healthcare Ltd.
![]() ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Presidente | - | - |
Formazione di William Collier
University of Manchester Institute of Science & Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Regno Unito | 3 |
Canada | 2 |
Posizioni
Director/Board Member | 4 |
President | 3 |
Chief Executive Officer | 2 |
Settori
Health Technology | 6 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Aziende private | 6 |
---|---|
International Partnership for Microbicides
![]() International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Health Technology |
Arbutus Biopharma, Inc.
![]() Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
Glaxowellcom | |
ViiV Healthcare Ltd.
![]() ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen. | Health Technology |
Aids United |
- Borsa valori
- Insiders
- William Collier
- Esperienza